Improvement of gene transfer to cervical cancer cell lines using non-viral agents

Cancer Letters

Volumn 162, Issue 1, 2001, Pages 75-85

  Cho, Cheong Weon ^a   Cho, Young Sik ^a   Kang, Byung Tae ^a   Hwang, Ji Sook ^a   Park, Sue Nie ^b   Yoon, Do Young ^a  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^b Korea Food and Drug Administration   (South Korea)

Author keywords

Gene delivery; Poloxamer 407; Polylysine; Virus like particle

Indexed keywords

BETA GALACTOSIDASE; CAPSID PROTEIN; CHLORAMPHENICOL ACETYLTRANSFERASE; POLOXAMER;

ARTICLE; CONTROLLED STUDY; ELECTRON MICROSCOPY; GENE TARGETING; GENE TRANSFER; HELA CELL; HUMAN; HUMAN CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE; UTERINE CERVIX CANCER; VIRUS PARTICLE; WART VIRUS;

CAPSID; FEMALE; GENE THERAPY; GENE TRANSFER TECHNIQUES; HELA CELLS; HUMANS; PAPILLOMAVIRIDAE; PLASMIDS; POLYLYSINE; TRANSFECTION;

CANCER VIRUS; CYTOMEGALOVIRUS; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPES; MIRIDAE; SIMIAE; SIMIAN VIRUS;

EID: 0035834876     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(00)00629-7     Document Type: Article

References (35)

1. The road toward human gene therapy-a 25-year perspective
2. Gene therapy vectors as drug delivery systems
3. Papillomavirus-like particle vaccines for cervical cancer
4. Papillomavirus-like particles and HPV vaccine development
5. Papillomavirus vaccines: Current status and future prospects
6. Papillomavirus-like particles for serology and vaccine development
7. Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particles
8. Expression of human papillomavirus type 11 L1 protein in insect cells: In vivo and in vitro assembly of viruslike particles
9. Interaction of human papillomavirus (HPV) type 16 capsid proteins with HPV DNA requires an intact L2 N-terminal sequence
10. Papillomavirus capsid binding and uptake by cells from different tissues and species
11. Interaction of papillomavirus with the cell surface
12. Binding and internalization of human papillomavirus type 33 virus-like particles by eukaryotic cells
13. Optimal techniques for arterial gene transfer
14. Pharmacokinetics of adenoviral vector-mediated gene delivery to vascular smooth muscle cells: Modulation by poloxamer 407 and implications for cardiovascular gene therapy
15. Improved efficiency of arterial gene transfer by use of poloxamer 407 as a vehicle for adenoviral vectors
16. Permeation of piroxicam from the poloxamer gels
17. Gene delivery by negatively charged ternary complexes of DNA, cationic liposomes and transferrin or fusogenic peptides
18. Peptide-mediated gene delivery: Influence of peptide structure on gene expression
19. Transferrin-polycation-mediated introduction of DNA into human leukemic cells: Stimulation by agents that affect the survival of transfected DNA or modulate transferrin receptor levels
20. Binding of cationic a-helical peptides to plasmid DNA and their gene transfer abilities into cells
21. Production of viruslike particles from human papillomavirus type 16 capsid protein L1 expressed in insect cells
22. Targeted delivery of DNA for gene therapy via receptors
23. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
24. Identification of proteins encoded by the L1 and L2 open reading frames of human papillomavirus 1a
25. Proteins present in bovine papillomavirusparticles
26. Surface relocation of alpha 4 beta 4 integrins and assembly of hemidesmosomes in and in vitro model of wound healing
27. Identification of the alpha6 integrin as a candidate receptor for papillomaviruses
28. In vitro gene transfer using human papillomavirus-like particles
29. Production of recombinant virus-like particles from human papillomavirus types 6 and 11, and study of serological reactivities between HPV 6, 11, 16 and 45 by ELISA: Implications for papillomavirus prevention and detection
30. Transferrin-polycation-DNA complexes: The effect of polycations on the structure of the complex and DNA delivery to cells
31. DNA-binding transferrin conjugates as functional gene-delivery agents: Synthesis by linkage of polylysine or ethidium homodimer to the transferrin carbohydrate moiety
32. Targeting genes: Delivery and persistent expression of a foreign gene driven by mammalian regulatory elements in vivo
33. Receptor-mediated gene delivery and expression in vivo
34. Expression of vaccinia recombinant HPV 16 L1 and L2 ORF proteins in epithelial cells is sufficient for assembly of HPV virion-like particles
35. Detection of antibodies against human papillomavirus (HPV) type 16 virions by enzyme-linked immunosorbent assay using recombinant HPV 16 L1 capsids produced by recombinant baculovirus